Jackson KK, Mata C, Marcus RK. A fast capillary-channeled polymer (C-CP) fiber spin-down tip strategy for the isolation of plant-derived extracellular vesicles (PDEVs) from 20 frequent fruit and vegetable sources. Talanta. 2022;252:123779.
Witwer KW, Wolfram J. Extracellular vesicles versus artificial nanoparticles for drug supply. Nat Evaluations Mater. 2021;6:103–6.
Zhang X, Zhang HB, Gu JM, Zhang JY, Shi H, Qian H, Wang DQ, Xu WR, Pan JM, Santos HA. Engineered extracellular vesicles for most cancers remedy. Adv Mater. 2021;33:25.
Van Niel G, D’Angelo G, Raposo G. Shedding mild on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213–28.
Wiklander OPB, Brennan MA, Lotval J, Breakefield XO, El Andaloussi S. Advances in therapeutic functions of extracellular vesicles. Sci Transl Med. 2019;11:15.
Luo RH, Liu MM, Tan TT, Yang Q, Wang Y, Males LH, Zhao LP, Zhang HH, Wang SL, Xie T, Tian QC. Rising significance and therapeutic potential of extracellular vesicles. Int J Biol Sci. 2021;17:2476–86.
Xue VW, Wong SCC, Tune GQ, Cho WCS. Promising RNA-based most cancers gene remedy utilizing extracellular vesicles for drug supply. Knowledgeable Opin Biol Ther. 2020;20:767–77.
Li AX, Zhao YA, Li YX, Jiang LD, Gu YW, Liu JY. Cell-derived biomimetic nanocarriers for focused most cancers remedy: cell membranes and extracellular vesicles. Drug Supply. 2021;28:1237–55.
Morad G, Carman CV, Hagedorn EJ, Perlin JR, Zon LI, Mustafaoglu N, Park TE, Ingber DE, Daisy CC, Moses MA. Tumor-derived extracellular vesicles breach the Intact blood-brain barrier through transcytosis. ACS Nano. 2019;13:13853–65.
Lee H, Park H, Noh GJ, Lee ES. pH-responsive hyaluronate-anchored extracellular vesicles to advertise tumor-targeted drug supply. Carbohydr Polym. 2018;202:323–33.
Galieva LR, James V, Mukhamedshina YO, Rizvanov AA. Therapeutic potential of extracellular vesicles for the therapy of nerve problems. Entrance NeuroSci. 2019;13:9.
Lee JR, Park BW, Kim J, Choo YW, Kim HY, Yoon JK, Kim H, Hwang JW, Kang M, Kwon SP, et al. Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac restore. Sci Adv. 2020;6:14.
Armstrong JPK, Stevens MM. Strategic design of extracellular vesicle drug supply techniques. Adv Drug Deliv Rev. 2018;130:12–6.
Solar DM, Zhuang XY, Xiang XY, Liu YL, Zhang SY, Liu CR, Barnes S, Grizzle W, Miller D, Zhang HG. A novel nanoparticle drug supply system: the anti-inflammatory exercise of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18:1606–14.
Hernandez-Oller L, Seras-Franzoso J, Andrade F, Rafael D, Abasolo I, Gener P, Schwartz S. Extracellular vesicles as drug supply techniques in most cancers. Pharmaceutics. 2020;12:20.
Sil S, Dagur RS, Liao Okay, Peeples ES, Hu GK, Periyasamy P, Buch S. Methods for using extracellular vesicles for the supply of therapeutics. J Neuroimmune Pharmacol. 2020;15:422–42.
Min L, Wang BS, Bao H, Li XR, Zhao LB, Meng JX, Wang ST. Superior nanotechnologies for extracellular vesicle-based liquid biopsy. Adv Sci. 2021;8:28.
Liu JL, Chen Y, Pei F, Zeng CM, Yao Y, Liao W, Zhao ZH. Extracellular vesicles in liquid biopsies: potential for illness prognosis. Biomed Res Int. 2021;2021:17.
Sharma S, Masud MK, Kaneti YV, Rewatkar P, Koradia A, Hossain MSA, Yamauchi Y, Popat A, Salomon C. Extracellular vesicle nanoarchitectonics for novel drug supply functions. Small. 2021;17:22.
Geng TJ, Pan PT, Leung E, Chen Q, Chamley L, Wu ZM. Latest development and technical challenges in creating small extracellular vesicles for most cancers drug supply. Pharm Res. 2021;38:179–97.
Gurunathan S, Kang MH, Qasim M, Khan Okay, Kim JH. Biogenesis, membrane trafficking, features, and subsequent technology nanotherapeutics medication of extracellular vesicles. Int J Nanomed. 2021;16:3357–83.
Teng F, Fussenegger M. Shedding mild on extracellular vesicle biogenesis and bioengineering. Adv Sci. 2021;8:17.
Pirisinu M, Pham TC, Zhang DX, Hong TN, Nguyen LT, Le MTN. Extracellular vesicles as pure therapeutic brokers and innate drug supply techniques for most cancers therapy: current advances, present obstacles, and challenges for scientific translation. Sem Most cancers Biol. 2022;80:340–55.
Stremersch S, De Smedt SC, Raemdonck Okay. Therapeutic and diagnostic functions of extracellular vesicles. J Managed Launch. 2016;244:167–83.
Stahl AL, Johansson Okay, Mossberg M, Kahn R, Karpman D. Exosomes and microvesicles in regular physiology, pathophysiology, and renal illnesses. Pediatr Nephrol. 2019;34:11–30.
Hessvik NP, Llorente A. Present data on exosome biogenesis and launch. Cell Mol Life Sci. 2018;75:193–208.
Leone DA, Rees AJ, Kain R. Dendritic cells and routing cargo into exosomes. Immunol Cell Biol. 2018;96:683–93.
Kalluri R, LeBleu VS. The biology, perform, and biomedical functions of exosomes. Science. 2020;367:640.
Michaela S, Aigner A. Nucleic acid supply with extracellular vesicles. Adv Drug Deliv Rev. 2021;173:89–111.
Juan T, Furthauer M. Biogenesis and performance of ESCRT-dependent extracellular vesicles. Semin Cell Dev Biol. 2018;74:66–77.
Schmidt O, Teis D. The ESCRT equipment. Curr Biol. 2012;22:R116–20.
Cabeza L, Perazzoli G, Pena M, Cepero A, Luque C, Melguizo C, Prados J. Most cancers remedy primarily based on extracellular vesicles as drug supply automobiles. J Managed Launch. 2020;327:296–315.
Dreyer F, Baur A. Biogenesis and features of exosomes and extracellular vesicles. Strategies Mol Biol (Clifton NJ). 2016;1448:201–16.
Patil AA, Rhee WJ. Exosomes: biogenesis, composition, features, and their function in pre-metastatic area of interest formation. Biotechnol Bioprocess Eng. 2019;24:689–701.
Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in most cancers metastasis and drug resistance. Mol Most cancers. 2019;18:14.
Cheng LS, Hill AF. Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discovery. 2022;21:379–99.
Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and different extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9–17.
Takahashi RU, Prieto-Vila M, Hironaka A, Ochiya T. The function of extracellular vesicle microRNAs in most cancers biology. Clin Chem Lab Med. 2017;55:648–56.
Zhu SL, Li SY, Yi M, Li N, Wu KM. Roles of microvesicles in tumor development and scientific functions. Int J Nanomed. 2021;16:7071–90.
Shao HL, Im H, Castro CM, Breakefield X, Weissleder R, Lee HH. New applied sciences for evaluation of extracellular vesicles. Chem Rev. 2018;118:1917–50.
Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S, Lange S. Microvesicles in well being and illness. Arch Immunol Ther Exp. 2012;60:107–21.
Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D’Souza-Schorey C. ARF6-Regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19:1875–85.
Tricarico C, Clancy J, D’Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases. 2017;8:220–32.
Atkin-Smith GK, Tixeira R, Paone S, Mathivanan S, Collins C, Liem M, Goodall KJ, Ravichandran KS, Hulett MD, Poon IKH. A novel mechanism of producing extracellular vesicles throughout apoptosis through a beads-on-a-string membrane construction. Nat Commun. 2015;6:10.
Caruso S, Poon IKH. Apoptotic cell-derived extracellular vesicles: extra than simply particles. Entrance Immunol. 2018;9:9.
Mentkowski KI, Snitzer JD, Rusnak S, Lang JK. Therapeutic potential of engineered extracellular vesicles. Aaps J. 2018;20:17.
Lane JD, Allan VJ, Woodman PG. Energetic relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci. 2005;118:4059–71.
Battistelli M, Falcieri E. Apoptotic our bodies: explicit extracellular vesicles concerned in intercellular communication. Biology-Basel. 2020;9:10.
Depraetere V. Eat me” indicators of apoptotic our bodies. Nat Cell Biol. 2000;2:E104–4.
Clancy JW, Sedgwick A, Rosse C, Muralidharan-Chari V, Raposo G, Methodology M, Chavrier P. D’Souza-Schorey C: regulated supply of molecular cargo to invasive tumour-derived microvesicles. Nat Commun. 2015;6:11.
Feng QY, Zhang CL, Lum D, Druso JE, Clean B, Wilson KF, Welm A, Antonyak MA, Cerione RA. A category of extracellular vesicles from breast most cancers cells prompts VEGF receptors and tumour angiogenesis. Nat Commun. 2017;8:17.
Fontana F, Carollo E, Melling GE, Carter DRF. Extracellular vesicles: rising modulators of most cancers drug resistance. Cancers. 2021;13:16.
Silachev DN, Goryunov KV, Shpilyuk MA, Beznoschenko OS, Morozova NY, Kraevaya EE, Popkov VA, Pevzner IB, Zorova LD, Evtushenko EA, et al. Impact of MSCs and MSC-Derived extracellular vesicles on human blood coagulation. Cells. 2019;8:23.
Malda J, Boere J, van de Lest CHA, van Weeren PR, Wauben AHM. Extracellular vesicles – new software for joint restore and regeneration. Nat Rev Rheumatol. 2016;12:243–9.
Wu WC, Tune SJ, Zhang Y, Li X. Position of extracellular vesicles in autoimmune pathogenesis. Entrance Immunol. 2020;11:9.
Agrahari V, Agrahari V, Burnouf PA, Chew CH, Burnouf T. Extracellular microvesicles as New Industrial Therapeutic Frontiers. Developments Biotechnol. 2019;37:707–29.
Xie F, Zhou XX, Fang MY, Li HY, Tu YF, Su P, Zhang L, Zhou FF. Extracellular vesicles in Most cancers Immune Microenvironment and Most cancers Immunotherapy. Adv Sci. 2019;6:18.
Herrmann IK, Wooden MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug supply platform. Nat Nanotechnol. 2021;16:748–59.
Pang BR, Zhu Y, Ni J, Thompson J, Malouf D, Bucci J, Graham P, Li Y. Extracellular vesicles: the subsequent technology of biomarkers for liquid biopsy-based prostate most cancers prognosis. Theranostics. 2020;10:2309–26.
Yang DB, Zhang WH, Zhang HY, Zhang FQ, Chen LM, Ma LX, Larcher LM, Chen SX, Liu N, Zhao QX, et al. Progress, alternative, and perspective on exosome isolation – efforts for environment friendly exosome-based theranostics. Theranostics. 2020;10:3684–707.
Taylor DD, Shah S. Strategies of isolating extracellular vesicles influence down-stream analyses of their cargoes. Strategies. 2015;87:3–10.
Kurian TK, Banik S, Gopal D, Chakrabarti S, Mazumder N. Elucidating strategies for isolation and quantification of Exosomes: a overview. Mol Biotechnol. 2021;63:249–66.
Heras KL, Royo F, Garcia-Vallicrosa C, Igartua M, Santos-Vizcaino E, Falcon-Perez JM, Hernandez RM. Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for continual wound therapeutic. Stem Cell Res Ther. 2022;13:18.
Li QY, Wang YL, Xue YY, Qiao LA, Yu GP, Liu YS, Yu SN. Ultrasensitive evaluation of exosomes utilizing a 3D self-assembled nanostructured SiO2 microfluidic chip. ACS Appl Mater Interfaces. 2022;14:14693–702.
Cvjetkovic A, Lotvall J, Lasser C. The affect of rotor sort and centrifugation time on the yield and purity of extracellular vesicles. J Extracell vesicles. 2014. https://doi.org/10.3402/jev.v3.23111.
Zhang MD, Jin Okay, Gao L, Zhang ZK, Li F, Zhou FF, Zhang L. Strategies and applied sciences for exosome isolation and characterization. Small Strategies. 2018;2:10.
Nordin JZ, Lee Y, Vader P, Mager I, Johansson HJ, Heusermann W, Wiklander OPB, Hallbrink M, Seow Y, Bultema JJ, et al. Ultrafiltration with size-exclusion liquid chromatography for top yield isolation of extracellular vesicles preserving intact biophysical and purposeful properties. Nanomedicine-Nanotechnol Biol Med. 2015;11:879–83.
Chen JC, Li PL, Zhang TY, Xu ZP, Huang XW, Wang RM, Du LT. Evaluate on methods and Applied sciences for Exosome isolation and purification. Entrance Bioeng Biotechnol. 2022;9:18.
Alzhrani GN, Alanazi ST, Alsharif SY, Albalawi AM, Alsharif AA, Abdel-Maksoud MS, Elsherbiny N. Exosomes: isolation, characterization, and biomedical functions. Cell Biol Int. 2021;45:1807–31.
Arab T, Raffo-Romero A, Van Camp C, Lemaire Q, Le Marrec-Croq F, Drago F, Aboulouard S, Slomianny C, Lacoste AS, Guigon I, et al. Proteomic characterisation of leech microglia extracellular vesicles (EVs): comparability between differential ultracentrifugation and optiprep (TM) density gradient isolation. J Extracell Vesicles. 2019;8:18.
Iwai Okay, Minamisawa T, Suga Okay, Yajima Y, Shiba Okay. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles. 2016;5:17.
Sidhom Okay, Obi PO, Saleem A. A overview of exosomal isolation strategies: is measurement exclusion chromatography the most suitable choice? Int J Mol Sci. 2020;21:19.
Monguio-Tortajada M, Moron-Font M, Gamez-Valero A, Carreras-Planella L, Borras FE, Franquesa M. Extracellular-vesicle isolation from completely different organic fluids by size-exclusion chromatography. Curr Protoc Stem Cell Biol. 2019;49:e82.
Foers AD, Chatfield S, Dagley LF, Scicluna BJ, Webb AI, Cheng L, Hill AF, Wicks IP, Pang KC. Enrichment of extracellular vesicles from human synovial fluid utilizing measurement exclusion chromatography. J Extracell Vesicles. 2018;7:13.
Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Feizi MAH, Nieuwland R, Lotvall J, Lasser C. Detailed evaluation of the plasma extracellular vesicle proteome after separation from lipoproteins. Cell Mol Life Sci. 2018;75:2873–86.
Guan S, Yu HL, Yan GQ, Gao MX, Solar WB, Zhang XM. Characterization of urinary exosomes purified with measurement exclusion chromatography and ultracentrifugation. J Proteome Res. 2020;19:2217–25.
Saad MG, Beyenal H, Dong WJ. Exosomes as highly effective engines in most cancers: isolation, characterization and detection methods. Biosensors-Basel. 2021;11:37.
Zhang Y, Bi JY, Huang JY, Tang YN, Du SY, Li PY. Exosome: a overview of its classification, isolation methods, Storage, Diagnostic and focused remedy functions. Int J Nanomed. 2020;15:6917–34.
Paterna A, Rao ESL, Adamo G, Raccosta S, Picciotto S, Romancino D, Noto R, Touzet N, Bongiovanni A, Manno M. Isolation of extracellular vesicles from microalgae: a renewable and scalable bioprocess. Entrance Bioeng Biotechnol. 2022;10:12.
Busatto S, Vilanilam G, Ticer T, Lin WL, Dickson DW, Shapiro S, Bergese P, Wolfram J. Tangential movement filtration for extremely environment friendly focus of extracellular vesicles from giant volumes of fluid. Cells. 2018;7:11.
He LQ, Zhu D, Wang JP, Wu XY. A extremely environment friendly methodology for isolating urinary exosomes. Int J Mol Med. 2019;43:83–90.
Parimon T, Garrett NE, Chen P, Antes TJ. Isolation of extracellular vesicles from murine bronchoalveolar lavage fluid utilizing an ultrafiltration centrifugation approach. Jove-J Vis Exp. 2018. https://doi.org/10.3791/58310.
Cardoso RMS, Rodrigues SC, Gomes CF, Duarte FV, Romao M, Leal EC, Freire PC, Neves R, Simoes-Correia J. Growth of an optimized and scalable methodology for isolation of umbilical wire blood-derived small extracellular vesicles for future scientific use. Stem Cells Transl Med. 2021;10:910–21.
Zhang HY, Lyden D. Uneven-flow field-flow fractionation know-how for exomere and small extracellular vesicle separation and characterization. Nat Protoc. 2019;14:1027–53.
Zhang P, Yeo JC, Lim CT. Advances in applied sciences for purification and enrichment of extracellular vesicles. Slas Technol. 2019;24:477–88.
Wu BW, Chen XL, Wang JF, Qing XQ, Wang ZP, Ding X, Xie ZS, Niu LL, Guo XJ, Cai TX, et al. Separation and characterization of extracellular vesicles from human plasma by asymmetrical movement field-flow fractionation. Anal Chim Acta. 2020;1127:234–45.
Kang DJ, Oh S, Ahn SM, Lee BH, Moon MH. Proteomic evaluation of exosomes from human neural stem cells by movement field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. J Proteome Res. 2008;7:3475–80.
Yang JS, Lee JC, Byeon SK, Rha KH, Moon MH. Dimension dependent lipidomic evaluation of urinary exosomes from sufferers with prostate most cancers by movement field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. Anal Chem. 2017;89:2488–96.
Martins TS, Catita J, Rosa IM, Silva O, Henriques AG. Exosome isolation from distinct biofluids utilizing precipitation and column-based approaches. PLoS ONE. 2018;13:16.
Ludwig AK, De Miroschedji Okay, Doeppner TR, Borger V, Ruesing J, Rebmann V, Durst S, Jansen S, Bremer M, Behrmann E, et al. Precipitation with polyethylene glycol adopted by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue tradition supernatants in small and enormous scales. J Extracell Vesicles. 2018;7:20.
Martinez-Greene JA, Hernandez-Ortega Okay, Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair DA, Budnik B, Hidalgo-Miranda A, Uribe-Querol E, Ramos-Godinez MD, Martinez-Martinez E. Quantitative proteomic evaluation of extracellular vesicle subgroups remoted by an optimized methodology combining polymer-based precipitation and measurement exclusion chromatography. J Extracell Vesicles. 2021;10:20.
Karttunen J, Heiskanen M, Navarro-Ferrandis V, Das Gupta S, Lipponen A, Puhakka N, Rilla Okay, Koistinen A, Pitkanen A. Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs. J Extracell Vesicles. 2019;8:10.
Garcia-Romero N, Madurga R, Rackov G, Palacin-Aliana I, Nunez-Torres R, Asensi-Puig A, Carrion-Navarro J, Esteban-Rubio S, Peinado H, Gonzalez-Neira A, et al. Polyethylene glycol improves present strategies for circulating extracellular vesicle-derived DNA isolation. J Translational Med. 2019;17:11.
Deregibus MC, Figliolini F, D’Antico S, Manzini PM, Pasquino C, De Lena M, Tetta C, Brizzi MF, Camussi G. Cost-based precipitation of extracellular vesicles. Int J Mol Med. 2016;38:1359–66.
Tan XH, Fang D, Xu YD, Nan TG, Tune WP, Gu YY, Gu SJ, Yuan YM, Xin ZC, Zhou LQ, et al. Skimmed bovine milk-derived extracellular vesicles remoted through “Salting-Out”: characterizations and potential features as Nanocarriers. Entrance Nutr. 2021;8:15.
Zhou SS, Hu T, Zhang F, Tang DZ, Li DK, Cao J, Wei W, Wu YF, Liu SQ. Built-in Microfluidic gadget for Correct Extracellular Vesicle quantification and protein markers evaluation straight from human complete blood. Anal Chem. 2020;92:1574–81.
Chen YS, Chen C, Lai CPK, Lee GB. Isolation and digital counting of extracellular vesicles from blood through membrane-integrated microfluidics. Sens Actuators B. 2022;358:131473–3.
Gwak H, Park S, Yu H, Hyun KA, Jung HI. A modular microfluidic platform for serial enrichment and harvest of pure extracellular vesicles. Analyst. 2022;147:1117–27.
Han BH, Kim S, Search engine optimisation G, Heo Y, Chung S, Kang JY. Isolation of extracellular vesicles from small volumes of plasma utilizing a microfluidic aqueous two-phase system. Lab Chip. 2020;20:3552–9.
Solar N, Tran BV, Peng ZS, Wang J, Zhang C, Yang P, Zhang TX, Widjaja J, Zhang RY, Xia WX, et al. Coupling lipid labeling and click on chemistry allows isolation of extracellular vesicles for noninvasive detection of oncogenic gene alterations. Adv Sci. 2022;9:12.
Cheng J, Zhu NH, Zhang YJ, Yu Y, Kang Okay, Yi QY, Wu Y. Hedgehog-inspired immunomagnetic beads for high-efficient seize and launch of exosomes. J Mater Chem B. 2022;10:4059–69.
Yang KG, Jia MQ, Cheddah S, Zhang ZY, Wang WW, Li XY, Wang Y, Yan C. Peptide ligand-SiO2 microspheres with particular affinity for phosphatidylserine as a brand new technique to isolate exosomes and software in proteomics to distinguish hepatic most cancers. Bioactive Mater. 2022;15:343–54.
Brambilla D, Sola L, Ferretti AM, Chiodi E, Zarovni N, Fortunato D, Criscuoli M, Dolo V, Giusti I, Murdica V, et al. EV separation: launch of intact extracellular vesicles immunocaptured on magnetic particles. Anal Chem. 2021;93:5476–83.
Dao TNT, Kim MG, Koo B, Liu HF, Jang YO, Lee HJ, Kim Y, Park YY, Kim HS, Kim CS, Shin Y. Chimeric nanocomposites for the fast and easy isolation of urinary extracellular vesicles. J Extracell Vesicles. 2022;11:20.
Cho S, Jo W, Heo Y, Kang JY, Kwak R, Park J. Isolation of extracellular vesicle from blood plasma utilizing electrophoretic migration by way of porous membrane. Sens Actuators B-Chemical. 2016;233:289–97.
Zhang Y, Deng Z, Lou DD, Wang Y, Wang R, Hu R, Zhang X, Zhu QF, Chen YC, Liu F. Excessive-efficiency separation of Extracellular vesicles from lipoproteins in plasma by Agarose Gel Electrophoresis. Anal Chem. 2020;92:7493–9.
Search engine optimisation N, Nakamura J, Kaneda T, Tateno H, Shimoda A, Ichiki T, Furukawa Okay, Hirabayashi J, Akiyoshi Okay, Shiku H. Distinguishing purposeful exosomes and different extracellular vesicles as a nucleic acid cargo by the anion-exchange methodology. J Extracell Vesicles. 2022;11:18.
Walker S, Busatto S, Pham A, Tian M, Suh A, Carson Okay, Quintero A, Lafrence M, Malik H, Santana MX, Wolfram J. Extracellular vesicle-based drug supply techniques for most cancers therapy. Theranostics. 2019;9:8001–17.
Xi XM, Chen M, Xia SJ, Lu R. Drug loading methods for exosome-based drug supply techniques. Pharmazie. 2021;76:61–7.
Xu C, Zhai ZJ, Ying H, Lu L, Zhang J, Zeng YM. Curcumin primed ADMSCs derived small extracellular vesicle exert enhanced protecting results on osteoarthritis by inhibiting oxidative stress and chondrocyte apoptosis. J Nanobiotechnol. 2022;20:16.
Kim S, Kang JH, Cao TGN, Kang SJ, Jeong Okay, Kang HC, Kwon YJ, Rhee WJ, Ko YT, Shim MS. Extracellular vesicles with excessive twin drug loading for secure and environment friendly mixture chemo-phototherapy. Biomaterials Sci. 2022;10:2817–30.
Kim JK, Youn YJ, Lee YB, Kim SH, Tune DK, Shin M, Jin HK, Bae JS, Shrestha S, Hong CW. Extracellular vesicles from dHL-60 cells as supply automobiles for numerous therapeutics. Sci Rep. 2021;11:11.
Qiu YL, Solar JM, Qiu JP, Chen GL, Wang X, Mu YX, Li KS, Wang WJ. Antitumor Exercise of Cabazitaxel and MSC-TRAIL Derived Extracellular vesicles in drug-resistant oral squamous cell carcinoma. Most cancers Handle Res. 2020;12:10809–20.
Yang Z, Yang Y, Xu YC, Jiang WQ, Shao Y, Xing JH, Chen YB, Han Y. Biomimetic nerve steerage conduit containing engineered exosomes of adipose-derived stem cells promotes peripheral nerve regeneration. Stem Cell Res Ther. 2021;12:14.
Yuana Y, Balachandran B, van der Wurff-Jacobs KMG, Schiffelers RM, Moonen CT. Potential use of extracellular vesicles generated by microbubble-assisted ultrasound as drug nanocarriers for most cancers therapy. Int J Mol Sci. 2020;21:3024.
Zeng WP, Wen ZB, Chen HL, Duan YY. Exosomes as carriers for drug supply in Most cancers Remedy. Pharm Res. 2023;40:873–87.
Jorquera-Cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Extracellular vesicles from M1-Polarized macrophages mixed with hyaluronic acid and a beta-blocker potentiate doxorubicin’s antitumor exercise by downregulating tumor-associated macrophages in breast most cancers. Pharmaceutics. 2022. https://doi.org/10.3390/pharmaceutics14051068.
Gong CA, Tian J, Wang Z, Gao Y, Wu X, Ding XY, Qiang L, Li GR, Han ZM, Yuan YF, Gao S. Useful exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast most cancers remedy. J Nanobiotechnol. 2019;17:18.
Li HZ, Xu W, Li F, Zeng R, Zhang XM, Wang XW, Zhao SJ, Weng J, Li Z, Solar LP. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles. Drug Supply. 2022;29:192–202.
Haney MJ, Zhao YL, Jin YS, Li SM, Bago JR, Klyachko NL, Kabanov AV, Batrakova EV. Macrophage-derived extracellular vesicles as drug supply techniques for triple damaging breast most cancers (TNBC) remedy. J Neuroimmune Pharmacol. 2020;15:487–500.
Ayed Z, Cuvillier L, Dobhal G, Goreham RV. Electroporation of outer membrane vesicles derived from Pseudomonas aeruginosa with gold nanoparticles. Sn Appl Sci. 2019;1:9.
Zhu SQ, Huang HY, Liu D, Wen SM, Shen LL, Lin QK. Augmented mobile uptake and homologous concentrating on of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety enchancment. Bioactive Mater. 2022;15:469–81.
Li BY, Chen X, Qiu W, Zhao RR, Duan JZ, Zhang SJ, Pan ZW, Zhao SL, Guo QD, Qi YH, et al. Synchronous disintegration of ferroptosis protection axis through engineered exosome-conjugated magnetic nanoparticles for glioblastoma remedy. Adv Sci. 2022;9:13.
Tsai HI, Wu YY, Liu XY, Xu ZX, Liu LS, Wang CX, Zhang HX, Huang YS, Wang LL, Zhang WX, et al. Engineered Small Extracellular vesicles as a FGL1/PD-L1 dual-targeting supply system for assuaging Immune rejection. Adv Sci. 2022;9:13.
Tian R, Wang ZS, Niu RF, Wang HJ, Guan WJ, Chang J. Tumor exosome mimicking nanoparticles for tumor combinatorial chemo-photothermal remedy. Entrance Bioeng Biotechnol. 2020;8:11.
Peng H, Li Y, Ji WH, Zhao RC, Lu ZG, Shen J, Wu YY, Wang JZ, Hao QL, Wang JW, et al. Intranasal administration of self-oriented nanocarriers primarily based on therapeutic exosomes for synergistic therapy of Parkinson’s illness. ACS Nano. 2022;16:869–84.
Yuan AR, Ruan L, Jia RD, Wang XF, Wu L, Cao J, Qi XY, Wei Y, Shen S. Tumor exosome-mimicking iron oxide nanoparticles for close to infrared-responsive drug supply. Acs Appl Nano Mater. 2022;5:996–1002.
Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale manufacturing, isolation, drug loading effectivity, and biodistribution and uptake. J Managed Launch. 2022;347:533–43.
Guo YH, Hu GW, Xia YG, Li HY, Yuan J, Zhang JT, Chen Y, Guo H, Yang YL, Wang Y, Deng ZF. Eliminating the unique cargos of glioblastoma cell-derived small extracellular vesicles for environment friendly drug supply to glioblastoma with improved biosafety. Bioactive Mater. 2022;16:204–17.
Cao TGN, Kang JH, Kim W, Lim J, Kang SJ, You JY, Hoang QT, Kim WJ, Rhee WJ, Kim C, et al. Engineered extracellular vesicle-based sonotheranostics for twin stimuli-sensitive drug launch and photoacoustic imaging-guided chemo-sonodynamic most cancers remedy. Theranostics. 2022;12:1247–66.
Cao TGN, Kang JH, You JY, Kang HC, Rhee WJ, Ko YT, Shim MS. Secure and focused Sonodynamic Most cancers Remedy utilizing Biocompatible Exosome-Based mostly nanosonosensitizers. ACS Appl Mater Interfaces. 2021;13:25575–88.
Thakur A, Sidu RK, Zou H, Alam MK, Yang MS, Lee YJ. Inhibition of glioma cells’ proliferation by doxorubicin-loaded exosomes through microfluidics. Int J Nanomed. 2020;15:8331–43.
Wang ZY, Wealthy J, Hao NJ, Gu YY, Chen CY, Yang SJ, Zhang PR, Huang TJ. Acoustofluidics for simultaneous nanoparticle-based drug loading and exosome encapsulation. Microsyst Nanoeng. 2022;8:11.
Jiang YY, Li JD, Xue X, Yin ZF, Xu Okay, Su JC. Engineered extracellular vesicles for bone remedy. Nano At this time. 2022;44:23.
Malekian F, Shamsian A, Kodam SP, Ullah M. Exosome engineering for environment friendly and focused drug supply: present standing and future perspective. J Physiol. 2022. https://doi.org/10.1113/JP282799.
Xu M, Feng T, Liu BW, Qiu F, Xu YH, Zhao YH, Zheng Y. Engineered exosomes: fascinating target-tracking traits for cerebrovascular and neurodegenerative illness therapies. Theranostics. 2021;11:8926–44.
Kwon S, Shin S, Do M, Oh BH, Tune Y, Bui VD, Lee ES, Jo DG, Cho YW, Kim DH, Park JH. Engineering approaches for efficient therapeutic functions primarily based on extracellular vesicles. J Managed Launch. 2021;330:15–30.
Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Useful extracellular vesicles for regenerative medication. Small. 2022;18:25.
Xu SY, Liu B, Fan JY, Xue CL, Lu Y, Li C, Cui DX. Engineered mesenchymal stem cell-derived exosomes with excessive CXCR4 ranges for focused siRNA gene remedy in opposition to most cancers. Nanoscale. 2022;14:4098–113.
Zhai X, Chen Okay, Yang H, Li B, Zhou TJK, Wang HJ, Zhou HP, Chen SF, Zhou XY, Wei XZ, et al. Extracellular vesicles derived from CD73 modified human umbilical wire mesenchymal stem cells ameliorate irritation after spinal wire damage. J Nanobiotechnol. 2021;19:20.
Zhu QQ, Tang SL, Zhu YW, Chen D, Huang JLY, Lin JY. Exosomes Derived from CTF1-Modified bone marrow stem cells promote endometrial regeneration and restore fertility. Entrance Bioeng Biotechnol. 2022;10:13.
Zhang J, Yao TT, Wang YX, Yu J, Liu YY, Lin ZQ. Lengthy noncoding RNA MEG3 is downregulated in cervical most cancers and impacts cell proliferation and apoptosis by regulating miR-21. Most cancers Biol Ther. 2016;17:104–13.
Huang X, Wu W, Jing DD, Yang LK, Guo HY, Wang LT, Zhang WY, Pu FF, Shao ZW. Engineered exosome as focused lncRNA MEG3 supply automobiles for osteosarcoma remedy. J Managed Launch. 2022;343:107–17.
Huang JH, Yu MY, Yin WJ, Liang B, Li A, Li JF, Li XL, Zhao SC, Liu F. Growth of a novel RNAi remedy: Engineered miR-31 exosomes promoted the therapeutic of diabetic wounds. Bioactive Mater. 2021;6:2841–53.
Zhao ZX, Shuang T, Gao Y, Lu F, Zhang JB, He W, Qu LJ, Chen BL, Hao Q. Focused supply of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. Most cancers Lett. 2022;530:45–58.
Fan XY, Li J, Chen PR. Bioorthogonal chemistry in residing animals. Natl Sci Rev. 2017;4:300–2.
Wang M, Altinoglu S, Takeda YS, Xu QB. Integrating protein engineering and bioorthogonal click on conjugation for extracellular vesicle modulation and intracellular supply. PLoS ONE. 2015;10:12.
Tune S, Shim MK, Lim S, Moon Y, Yang S, Kim J, Hong Y, Yoon HY, Kim IS, Hwang KY, Kim Okay. In situ one-step fluorescence labeling technique of exosomes through bioorthogonal click on chemistry for real-time exosome monitoring in vitro and in vivo. Bioconjug Chem. 2020;31:1562–74.
Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, Huang NP, Xiao ZD, Lu ZH, Tannous BA, Gao J. Floor functionalized exosomes as focused drug supply automobiles for cerebral ischemia remedy. Biomaterials. 2018;150:137–49.
Xu LZ, Faruqu FN, Liam-or R, Abu Abed O, Li DY, Venner Okay, Errington RJ, Summers H, Wang J, Al-Jamal KT. Design of experiment (DoE)-driven in vitro and in vivo uptake research of exosomes for pancreatic most cancers supply enabled by copper-free click on chemistry-based labelling. J Extracell Vesicles. 2020;9:19.
Zheng D, Ruan H, Chen W, Zhang Y, Cui W, Chen H, Shen H. Advances in extracellular vesicle functionalization methods for tissue regeneration. Bioactive Mater. 2022. https://doi.org/10.1016/j.bioactmat.2022.07.022.
Rayamajhi S, Aryal S. Floor functionalization methods of extracellular vesicles. J Mater Chem B. 2020;8:4552–69.
Zhou X, Miao YQ, Wang Y, He SF, Guo LM, Mao JS, Chen MS, Yang YT, Zhang XX, Gan Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles improve siRNA supply by tumour-homing and intracellular freeway transportation. J Extracell Vesicles. 2022;11:16.
Ishikawa R, Yoshida S, Sawada S, Sasaki Y, Akiyoshi Okay. Growth and single-particle evaluation of hybrid extracellular vesicles fused with liposomes utilizing viral fusogenic proteins. Febs Open Bio. 2022;12:1178–87.
Li LX, He D, Guo QQ, Zhang ZY, Ru D, Wang LT, Gong Okay, Liu FF, Duan YR, Li H. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian most cancers. J Nanobiotechnol. 2022;20:22.
Solar LN, Fan MR, Huang D, Li BQ, Xu RT, Gao F, Chen YZ. Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug supply to pulmonary fibrosis. Biomaterials. 2021;271:14.
Cheng LL, Zhang XG, Tang JJ, Lv QJ, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 sign for mixed photothermal remedy and most cancers immunotherapy. Biomaterials. 2021;275:15.
Piffoux M, Silva AKA, Wilhelm C, Gazeau F, Tareste D. Modification of Extracellular vesicles by Fusion with Liposomes for the design of Customized Biogenic Drug Supply Programs. ACS Nano. 2018;12:6830–42.
Rayamajhi S, Nguyen TDT, Marasini R, Aryal S. Macrophage-derived exosome-mimetic hybrid vesicles for tumor focused drug supply. Acta Biomater. 2019;94:482–94.
Tamura R, Uemoto S, Tabata Y. Augmented liver concentrating on of exosomes by floor modification with cationized pullulan. Acta Biomater. 2017;57:274–84.
Hu SQ, Wang XY, Li ZH, Zhu DS, Cores J, Wang ZZ, Li JL, Mei X, Cheng X, Su T, Cheng Okay. Platelet membrane and stem cell exosome hybrids improve mobile uptake and concentrating on to coronary heart damage. Nano At this time. 2021;39:12.
Li QY, Tune YN, Wang QZ, Chen J, Gao JF, Tan HP, Li S, Wu Y, Yang HB, Huang HW, et al. Engineering extracellular vesicles with platelet membranes fusion enhanced focused therapeutic angiogenesis in a mouse mannequin of myocardial ischemia reperfusion. Theranostics. 2021;11:3916–31.
Man Okay, Brunet MY, Jones MC, Cox SC. Engineered Extracellular vesicles: tailored-made nanomaterials for medical functions. Nanomaterials. 2020;10:30.
Liang SF, Zuo FF, Yin BC, Ye BC. Supply of siRNA primarily based on engineered exosomes for glioblastoma remedy by concentrating on STAT3. Biomaterials Sci. 2022;10:1582–90.
Ruan H, Li Y, Wang C, Jiang Y, Han Y, Li Y, Zheng D, Ye J, Chen G, Yang G-y, et al. Click on chemistry extracellular vesicle/peptide/chemokine nanocarriers for treating central nervous system accidents. Acta Pharm Sinica B. 2022. https://doi.org/10.1016/j.apsb.2022.06.007.
Fan B, Yang S, Wang YY, Zhang C, Yang JP, Wang LQ, Lv ZQ, Shi XF, Fan ZZ, Yang JK. Indocyanine green-loaded exosomes for image-guided glioma nano-therapy. J Exp Nanosci. 2022;17:187–96.
Wu Q, Fu XL, Li X, Li J, Han WJ, Wang YJ. Modification of adipose mesenchymal stem cells-derived small extracellular vesicles with fibrin-targeting peptide CREKA for enhanced bone restore. Bioactive Mater. 2023;20:208–20.
Rehman FU, Liu Y, Yang Q, Yang H, Liu R, Zhang D, Muhammad P, Liu Y, Hanif S, Ismail M, et al. Heme Oxygenase-1 concentrating on exosomes for temozolomide resistant glioblastoma synergistic remedy. J Management Launch. 2022;345:696–708.
Wang CY, Kimura Okay, Li JC, Richardson JJ, Naito M, Miyata Okay, Ichiki T, Ejima H. Polydopamine-mediated floor functionalization of exosomes. Chemnanomat. 2021;7:592–5.
Cui YZ, Guo YY, Kong L, Shi JY, Liu P, Li R, Geng YT, Gao WH, Zhang ZP, Fu DH. A bone-targeted engineered exosome platform delivering siRNA to deal with osteoporosis. Bioactive Mater. 2022;10:207–21.
Chen CX, Solar MD, Liu X, Wu WJ, Su LY, Li YM, Liu G, Yan XM. Basic and delicate modification of food-derived extracellular vesicles for enhanced cell concentrating on. Nanoscale. 2021;13:3061–9.
Bernardi S, Balbi C. Extracellular vesicles: from biomarkers to therapeutic instruments. Biology-Basel. 2020;9:6.
Ke CH, Hou H, Su Okay, Huang CH, Yuan Q, Li SY, Solar JW, Lin Y, Wu CB, Zhao Y, Yuan ZQ. Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for focused remedy of resistant tumors. Biomaterials Sci. 2022;10:1498–514.
Liu Y, Luo JS, Chen XJ, Liu W, Chen TK. Cell membrane coating know-how: a promising technique for biomedical functions. Nano-Micro Lett. 2019;11:46.
Riley RS, June CH, Langer R, Mitchell MJ. Supply applied sciences for most cancers immunotherapy. Nat Rev Drug Discovery. 2019;18:175–96.
Nie WD, Wu GH, Zhang JF, Huang LL, Ding JJ, Jiang AQ, Zhang YH, Liu YH, Li JC, Pu KY, Xie HY. Responsive exosome nano-bioconjugates for synergistic most cancers remedy. Angew Chem Int Ed. 2020;59:2018–22.
Zhang JH, Ji C, Zhang HB, Shi H, Mao F, Qian H, Xu WR, Wang DQ, Pan JM, Fang XJ, et al. Engineered neutrophil-derived exosome-like vesicles for focused most cancers remedy. Sci Adv. 2022;8:13.
Zhang MJ, Shao WX, Yang TR, Liu HL, Guo S, Zhao DY, Weng YH, Liang XJ, Huang YY. Conscription of Immune cells by light-activatable silencing NK-Derived Exosome (LASNEO) for synergetic tumor eradication. Adv Sci. 2022;9:15.
Zhou WX, Zhou Y, Chen XL, Ning TT, Chen HY, Guo Q, Zhang YW, Liu PX, Zhang YJ, Li C, et al. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2021;268:12.
Ortiz-Bonilla CJ, Uccello TP, Gerber SA, Lord EM, Messing EM, Lee YF. Bladder most cancers extracellular vesicles elicit a CD8 T cell-mediated antitumor immunity. Int J Mol Sci. 2022;23:15.
Wang RN, Liang QF, Zhang XR, Di ZN, Wang XH, Di LQ. Tumor-derived exosomes reversing TMZ resistance by synergistic drug supply for glioma-targeting therapy. Colloids Surf B Biointerfaces. 2022;215:11.
Wang J, Tang W, Yang M, Yin Y, Li H, Hu FF, Tang L, Ma XY, Zhang Y, Wang YZ. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug supply system for focused glioma remedy. Biomaterials. 2021;273:12.
Ge RF, Cao J, Chi JN, Han SC, Liang Y, Xu LS, Liang MT, Solar Y. NIR-guided dendritic nanoplatform for bettering antitumor efficacy by combining chemo-phototherapy. Int J Nanomed. 2019;14:4931–47.
Ma YY, Zhang YQ, Han R, Li Y, Zhai YW, Qian ZY, Gu YQ, Li SW. A cascade synergetic technique induced by photothermal impact primarily based on platelet exosome nanoparticles for tumor remedy. Biomaterials. 2022;282:13.
Liu J, Yi KZ, Zhang Q, Xu H, Zhang XG, He D, Wang FB, Xiao XH. Sturdy Penetration-Induced Efficient Photothermal remedy by exosome-mediated black Phosphorus Quantum Dots. Small. 2021;17:9.
Zhu DM, Zhang TF, Li Y, Huang CY, Suo M, Xia LG, Xu YH, Li GX, Tang BZ. Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine hunger remedy and enhanced type-I photodynamic remedy. Biomaterials. 2022;283:8.
Du JB, Wan Z, Wang C, Lu F, Wei MY, Wang DS, Hao Q. Designer exosomes for focused and environment friendly ferroptosis induction in most cancers through chemo-photodynamic remedy. Theranostics. 2021;11:8185–96.
Bose RJC, Kumar US, Garcia-Marques F, Zeng YT, Habte F, McCarthy JR, Pitteri S, Massoud TF, Paulmurugan R. Engineered cell-derived vesicles displaying concentrating on peptide and functionalized with nanocarriers for therapeutic microRNA supply to triple-negative breast most cancers in mice. Adv Healthc Mater. 2022;11:13.
Tao HY, Xu HL, Zuo L, Li C, Qiao G, Guo MY, Zheng LH, Leitgeb M, Lin XK. Exosomes-coated bcl-2 siRNA inhibits the expansion of digestive system tumors each in vitro and in vivo. Int J Biol Macromol. 2020;161:470–80.
Yuan L, Liu YQ, Qu YH, Liu L, Li HX. Exosomes derived from MicroRNA-148b-3p-Overexpressing human umbilical wire mesenchymal stem cells restrain breast Most cancers development. Entrance Oncol. 2019;9:14.
Wang XJ, Ding H, Li ZY, Peng YN, Tan H, Wang CL, Huang GD, Li WP, Ma GH, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for efficient accumulation in glioblastoma and robust synergistic therapeutic results. Sign Transduct Goal Ther. 2022;7:16.
Huang HQ, Shao LL, Chen Y, Tang L, Liu TQ, Li JX, Zhu HY. Synergistic technique with hyperthermia remedy primarily based immunotherapy and engineered exosomes-liposomes focused chemotherapy prevents tumor recurrence and metastasis in superior breast most cancers. Bioeng Translational Med. 2022;7:18.
Pan SJ, Zhang YH, Huang M, Deng ZF, Zhang A, Pei LJ, Wang LR, Zhao WY, Ma LJ, Zhang Q, Cui DX. Urinary exosomes-based engineered nanovectors for homologously focused chemo-chemodynamic prostate most cancers remedy through abrogating EGFR/AKT/NF-kB/IkB signaling. Biomaterials. 2021;275:13.
Wang XW, Zhang YM, Mu XF, Tu CR, Chung Y, Tsao SW, Chan GCF, Leung WH, Lau YL, Liu YP, Tu WW. Exosomes derived from gamma delta-T cells synergize with radiotherapy and protect antitumor actions in opposition to nasopharyngeal carcinoma in immunosuppressive microenvironment. J Immunother Most cancers. 2022;10:15.
Chen Okay, Si YN, Guan JS, Zhou ZX, Kim S, Kim T, Shan L, Willey CD, Zhou LF, Liu XG. Focused extracellular vesicles delivered Verrucarin A to deal with Glioblastoma. Biomedicines. 2022;10:15.
Yang ZM, Li YY, Wang ZH. Latest advances within the software of mesenchymal stem cell-derived exosomes for cardiovascular and neurodegenerative illness therapies. Pharmaceutics. 2022;14:18.
Ferrantelli F, Chiozzini C, Leone P, Manfredi F, Federico M. Engineered extracellular vesicles/exosomes as a brand new software in opposition to neurodegenerative illnesses. Pharmaceutics. 2020;12:17.
Salarpour S, Barani M, Pardakhty A, Khatami M, Chauhan NPS. The appliance of exosomes and exosome-nanoparticle in treating mind problems. J Mol Liq. 2022;350:15.
Cheng GW, Liu YJ, Ma R, Cheng GP, Guan YC, Chen XJ, Wu ZF, Chen TK. Anti-parkinsonian remedy: methods for crossing the blood-brain barrier and nano-biological results of nanomaterials. Nano-Micro Lett. 2022;14:49.
Zhao YL, Haney MJ, Fallon JK, Rodriguez M, Swain CJ, Arzt CJ, Smith PC, Loop MS, Harrison EB, El-Hage N, Batrakova EV. Utilizing extracellular vesicles launched by GDNF-Transfected macrophages for remedy of Parkinson illness. Cells. 2022;11:21.
Wang Q, Li T, Yang JY, Zhao ZA, Tan KY, Tang SW, Wan MM, Mao C. Engineered exosomes with impartial module/cascading perform for remedy of parkinson’s illness by multistep concentrating on and multistage intervention methodology. Adv Mater. 2022;34:14.
Wang YL, Pang JY, Wang QY, Yan LC, Wang LT, Xing Z, Wang CM, Zhang JF, Dong L. Delivering antisense oligonucleotides throughout the blood-brain barrier by Tumor Cell-Derived Small apoptotic our bodies. Adv Sci. 2021;8:13.
Xue CL, Li XC, Ba L, Zhang MJ, Yang Y, Gao Y, Solar Z, Han Q, Zhao RCH. MSC-Derived exosomes can improve the angiogenesis of human mind MECs and present therapeutic potential in a mouse mannequin of Parkinson’s illness. Ageing and Illness. 2021;12:1211–22.
Izco M, Blesa J, Schleef M, Schmeer M, Porcari R, Al-Shawi R, Ellmerich S, de Toro M, Gardiner C, Seow Y, et al. Systemic exosomal supply of shRNA minicircles prevents Parkinsonian Pathology. Mol Ther. 2019;27:2111–22.
Kojima R, Bojar D, Rizzi G, Hamri GCE, El-Baba MD, Saxena P, Auslander S, Tan KR, Fussenegger M. Designer exosomes produced by implanted cells intracerebrally ship therapeutic cargo for Parkinson’s illness therapy. Nat Commun. 2018;9:10.
Wang H, Sui HJ, Zheng Y, Jiang YB, Shi YJ, Liang J, Zhao L. Curcumin-primed exosomes potently ameliorate cognitive perform in AD mice by inhibiting hyperphosphorylation of the tau protein by way of the AKT/GSK-3 beta pathway. Nanoscale. 2019;11:7481–96.
Qi Y, Guo L, Jiang YB, Shi YJ, Sui HJ, Zhao L. Mind supply of quercetin-loaded exosomes improved cognitive perform in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Supply. 2020;27:745–55.
Li M, Fang F, Solar M, Zhang YF, Hu M, Zhang JF. Extracellular vesicles as bioactive nanotherapeutics: an rising paradigm for regenerative medication. Theranostics. 2022;12:4879–903.
Zarubova J, Hasani-Sadrabadi MM, Dashtimoghadam E, Zhang XX, Ansari S, Li S, Moshaverinia A. Engineered supply of dental stem-cell-derived extracellular vesicles for periodontal tissue regeneration. Adv Healthc Mater. 2022;11:10.
Kim H, Jang Y, Kim EH, Jang H, Cho H, Han G, Tune HK, Kim SH, Yang Y. Potential of colostrum-derived exosomes for selling hair regeneration by way of the transition from telogen to anagen section. Entrance Cell Dev Biology. 2022;10:12.
Xia WZ, Li MX, Jiang XY, Huang X, Gu SC, Ye JQ, Zhu LX, Hou M, Zan T. Younger fibroblast-derived exosomal microRNA-125b transfers helpful results on aged cutaneous wound therapeutic. J Nanobiotechnol. 2022;20:17.
Li FY, Wu J, Li DY, Hao LZ, Li YQ, Yi D, Yeung KWK, Chen D, Lu WW, Pan HB, et al. Engineering stem cells to provide exosomes with enhanced bone regeneration results: an alternate technique for gene remedy. J Nanobiotechnol. 2022;20:23.
Lan YH, Xie HZ, Jin QR, Zhao XM, Shi Y, Zhou YY, Hu ZH, Ye Y, Huang XY, Solar YJ, et al. Extracellular vesicles derived from neural EGFL-Like 1-modified mesenchymal stem cells enhance acellular bone regeneration through the mir-25-5p-SMAD2 signaling axis. Bioactive Mater. 2022;17:457–70.
Ko KW, Park SY, Lee EH, Yoo YI, Kim DS, Kim JY, Kwon TG, Han DK. Built-in bioactive scaffold with polydeoxyribonucleotide and stem-cell-derived extracellular vesicles for kidney regeneration. ACS Nano. 2021;15:7575–85.
Tune BW, Lee CY, Kim R, Kim WJ, Lee HW, Lee MY, Kim J, Jeong JY, Chang W. Multiplexed concentrating on of miRNA-210 in stem cell-derived extracellular vesicles promotes selective regeneration in ischemic hearts. Exp Mol Med. 2021;53:695–708.
Luo ZW, Solar YY, Qi BJ, Lin JR, Chen YS, Xu YZ, Chen JW. Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness through let-7a/Tgfbr1 axis. Bioactive Mater. 2022;17:344–59.
Gao J, Wang SH, Wang ZJ. Excessive yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation remedy. Biomaterials. 2017;135:62–73.
Yan FL, Zhong ZR, Wang Y, Feng Y, Mei ZQ, Li H, Chen X, Cai L, Li CH. Exosome-based biomimetic nanoparticles focused to infected joints for enhanced therapy of rheumatoid arthritis. J Nanobiotechnol. 2020;18:15.
Ma C, Qi X, Wei YF, Li Z, Zhang HL, Li H, Yu FL, Pu YN, Huang YC, Ren YX. Amelioration of ligamentum flavum hypertrophy utilizing umbilical wire mesenchymal stromal cell-derived extracellular vesicles. Bioactive Mater. 2023;19:139–54.
Han HS, Lee H, You D, Nguyen V, Tune DG, Oh BH, Shin S, Choi JS, Kim JD, Pan CH, et al. Human adipose stem cell-derived extracellular nanovesicles for therapy of continual liver fibrosis. J Managed Launch. 2020;320:328–36.
Wang C, Xing CY, Li ZL, Liu YN, Li QY, Wang YX, Hu J, Yuan LJ, Yang GD. Bioinspired therapeutic platform primarily based on extracellular vesicles for prevention of arterial wall reworking in hypertension. Bioactive Mater. 2022;8:494–504.
Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protecting impact of Intravitreal Administration of Exosomes derived from mesenchymal stem cells on retinal ischemia. Curr Eye Res. 2017;42:1358–67.
Tang TT, Wang B, Lv LL, Liu BC. Extracellular vesicle-based Nanotherapeutics: rising frontiers in anti-inflammatory remedy. Theranostics. 2020;10:8111–29.
Kaneko S, Takasawa Okay, Asada Okay, Shinkai N, Bolatkan A, Yamada M, Takahashi S, Machino H, Kobayashi Okay, Komatsu M, Hamamoto R. Epigenetic mechanisms underlying COVID-19 pathogenesis. Biomedicines. 2021;9:15.
Rezabakhsh A, Mahdipour M, Nourazarian A, Habibollahi P, Sokullu E, Avci CB, Rahbarghazi R. Software of exosomes for the alleviation of COVID-19-related pathologies. Cell Biochem Funct. 2022;40:430–8.
Mazini L, Rochette L, Malka G. Exosomes contribution in COVID-19 sufferers’ therapy. J Translational Med. 2021;19:8.
Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes derived from bone marrow mesenchymal stem cells as therapy for extreme COVID-19. Stem Cells Dev. 2020;29:747–54.
Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Arber N, Poulakou G, Syrigos Okay, Rapti V, Xynogalas I, Leontis Okay, et al. Security and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) for the prevention of scientific deterioration in sufferers with average or extreme COVID-19: a section II, randomized, single-blinded examine. Open Discussion board Infect Dis. 2022. https://doi.org/10.1093/ofid/ofac492.991.
Gul F, Gonen ZB, Jones OY, Tasli NP, Zararsiz G, Unal E, Ozdarendeli A, Sahin F, Eken A, Yilmaz S, et al. A pilot examine for therapy of extreme COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM)). Entrance Immunol. 2022;13:8.
Thone MN, Kwon YJ. Extracellular blebs: artificially-induced extracellular vesicles for facile manufacturing and scientific translation. Strategies. 2020;177:135–45.
Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961.
Li S, Xu JL, Qian J, Gao XH. Engineering extracellular vesicles for most cancers remedy: current advances and challenges in scientific translation. Biomaterials Sci. 2020;8:6978–91.
Bosch S, de Beaurepaire L, Allard M, Mosser M, Heichette C, Chretien D, Jegou D, Bach JM. Trehalose prevents aggregation of exosomes and cryodamage. Sci Rep. 2016;6:11.
Taghikhani A, Farzaneh F, Sharifzad F, Mardpour S, Ebrahimi M, Hassan ZM. Engineered tumor-derived extracellular vesicles: potentials in most cancers immunotherapy. Entrance Immunol. 2020;11:9.
Zhao Y, Li XL, Zhang WB, Yu LL, Wang Y, Deng Z, Liu MW, Mo SS, Wang RN, Zhao JM, et al. Developments within the organic features and medical functions of extracellular vesicles and analogues. Acta Pharm Sinica B. 2021;11:2114–35.
Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581–93.
Shirejini SZ, Inci F. The Yin and Yang of exosome isolation strategies: standard observe, microfluidics, and business kits. Biotechnol Adv. 2022;54:19.
Liu DSK, Upton FM, Rees E, Limb C, Jiao LR, Krell J, Frampton AE. Dimension-exclusion chromatography as a method for the investigation of novel extracellular vesicles in most cancers. Cancers. 2020;12:19.
Mohammadi M, Zargartalebi H, Salahandish R, Aburashed R, Yong KW, Sanati-Nezhad A. Rising applied sciences and business merchandise in exosome-based most cancers prognosis and prognosis. Biosens Bioelectron. 2021;183:27.
Janouskova O, Herma R, Semeradtova A, Poustka D, Liegertova M, Malinska HA, Maly J. Typical and nonconventional sources of exosomes-isolation strategies and affect on their downstream biomedical software. Entrance Mol Biosci. 2022;9:20.
Yu D, Li YX, Wang MY, Gu JM, Xu WR, Cai H, Fang XJ, Zhang X. Exosomes as a brand new frontier of most cancers liquid biopsy. Mol Most cancers. 2022;21:33.
Li P, Kaslan M, Lee SH, Yao J, Gao ZQ. Progress in Exosome isolation methods. Theranostics. 2017;7:789–804.
Haney MJ, Zhao YL, Jin YS, Batrakova EV. Extracellular vesicles as drug carriers for enzyme alternative remedy to deal with CLN2 Batten illness: optimization of drug administration routes. Cells. 2020;9:16.
Liu W, Yu MY, Chen F, Wang LQ, Ye C, Chen Q, Zhu Q, Xie D, Shao MZ, Yang LL. A novel supply nanobiotechnology: engineered miR-181b exosomes improved osteointegration by regulating macrophage polarization. J Nanobiotechnol. 2021;19:18.
Xiao Y, Tian J, Wu WC, Gao YH, Guo YX, Tune SJ, Gao R, Wang LB, Wu XY, Zhang Y, Li X. Concentrating on central nervous system extracellular vesicles enhanced triiodothyronine remyelination impact on experimental autoimmune encephalomyelitis. Bioactive Mater. 2022;9:373–84.
Han SQ, Li GC, Jia M, Zhao YL, He CL, Huang MX, Jiang LW, Wu MJ, Yang JH, Ji XQ, et al. Supply of Anti-miRNA-221 for colorectal carcinoma remedy utilizing modified wire blood mesenchymal stem cells-derived Exosomes. Entrance Mol Biosci. 2021;8:8.
Wu XY, Liao BY, Xiao D, Wu WC, Xiao Y, Alexander T, Tune SJ, Zhao ZH, Zhang YA, Wang ZH, et al. Encapsulation of bryostatin-1 by focused exosomes enhances remyelination and neuroprotection results within the cuprizone-induced demyelinating animal mannequin of a number of sclerosis. Biomaterials Sci. 2022;10:714–27.
Kim G, Lee Y, Ha J, Han S, Lee M. Engineering exosomes for pulmonary supply of peptides and medicines to inflammatory lung cells by inhalation. J Managed Launch. 2021;330:684–95.
Lin D, Zhang HY, Liu R, Deng T, Ning T, Bai M, Yang YC, Zhu KG, Wang JY, Duan JJ, et al. iRGD-modified exosomes successfully ship CPT1A siRNA to colon most cancers cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol. 2021;15:3430–46.
Lin Y, Wu JH, Gu WH, Huang YL, Tong ZC, Huang LJ, Tan JL. Exosome-liposome hybrid nanoparticles ship CRISPR/Cas9 system in MSCs. Adv Sci. 2018;5:9.
Matsuki Y, Yanagawa T, Sumiyoshi H, Yasuda J, Nakao S, Goto M, Shibata-Seki T, Akaike T, Inagaki Y. Modification of exosomes with carbonate apatite and a glycan polymer improves transduction effectivity and goal cell selectivity. Biochem Biophys Res Commun. 2021;583:93–9.
You DG, Oh BH, Nguyen V, Lim GT, Um W, Jung JM, Jeon J, Choi JS, Choi YC, Jung YJ, et al. Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by concentrating on activated hepatic stellate cells in vivo. J Managed Launch. 2021;336:285–95.
Li D, Yao SR, Zhou ZF, Shi J, Huang ZH, Wu ZM. Hyaluronan ornament of milk exosomes directs tumor -specific supply of doxorubicin. Carbohydr Res. 2020;493:5.
Zheng LR, Zhang BY, Chu HS, Cheng P, Li HY, Huang KL, He XY, Xu WT. Meeting andin vitroassessment of a robust mixture: aptamer-modified exosomes mixed with gold nanorods for efficient photothermal remedy. Nanotechnology. 2020;31:11.
Bagheri E, Abnous Okay, Farzad SA, Taghdisi SM, Ramezani M, Alibolandi M. Focused doxorubicin-loaded mesenchymal stem cells-derived exosomes as a flexible platform for combating in opposition to colorectal most cancers. Life Sci. 2020;261:10.
Kang CS, Han P, Lee JS, Lee D, Kim D. Anchor, Spacer, and ligand-modified Engineered Exosomes for Trackable focused remedy. Bioconjug Chem. 2020;31:2541–52.
Phung CD, Pham TT, Nguyen HT, Nguyen TT, Ou WQ, Jeong JH, Choi HG, Ku SK, Yong CS, Kim JO. Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes concentrating on tumor-draining lymph nodes for efficient induction of antitumor T-cell responses. Acta Biomater. 2020;115:371–82.
Li S, Wu YJ, Ding F, Yang JP, Li J, Gao XH, Zhang C, Feng J. Engineering macrophage-derived exosomes for focused chemotherapy of triple-negative breast most cancers. Nanoscale. 2020;12:10854–62.
Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, et al. A section I examine of dexosome immunotherapy in sufferers with superior non-small cell lung most cancers. J Translational Med. 2005;3:8.
Escudier B, Dorval T, Chaput N, Andre F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, et al. Vaccination of metastatic melanoma sufferers with autologous dendritic cell (DC) derived-exosomes: outcomes of thefirst section I scientific trial. J Translational Med. 2005;3:13.
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Section I scientific trial of autologous ascites-derived exosomes mixed with GM-CSF for colorectal most cancers. Mol Ther. 2008;16:782–90.
Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesik F, Laplanche A, et al. Dendritic cell-derived exosomes as upkeep immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 2016;5:13.
Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, Jin X, Liang X, Lv J, Zhang Y, et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in sufferers with extrahepatic cholangiocarcinoma. Nat Biomed Eng. 2020;4:743–53.